MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

被引：0

作者：

Harald Lund

Elin Gustafsson

Anne Svensson

Maria Nilsson

Margareta Berg

Dan Sunnemark

Gabriel von Euler

机构：

[1] iMed,Department of Neuroscience

[2] CNS and Pain Södertälje,Department of Clinical Neuroscience

[3] AstraZeneca Research and Development,undefined

[4] Center for Molecular Medicine,undefined

[5] Karolinska Institutet,undefined

来源：

Acta Neuropathologica Communications | / 2卷

关键词：

Alzheimer’s disease; MARK; Phosphorylation; Granulovacuolar degeneration bodies; Tau;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology
Shepherd, Claire E.
Affleck, Andrew J.
Bahar, Anita Y.
Carew-Jones, Francine
Halliday, Glenda M.
NEUROBIOLOGY OF AGING, 2020, 89 : 129 - 131
[22] GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease- like filaments
Chakraborty, Pijush
Purslow, Jeffrey A.
Fromm, Simon A.
Chatterjee, Debdeep
Zachrdla, Milan
Zhuang, Shannon
Puri, Sambhavi
Wolozin, Benjamin
Zweckstetter, Markus
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (52)
[23] Naringenin as a potent inhibitor molecule for targeting microtubule affinity-regulating kinase 4 (mark4): a molecular docking and in vitro study for therapeutics of Alzheimer's disease
Alam, Mohammad Zubair
Bagabir, Hala Abubaker
Zaher, Mohammad Alameen Faisal
Alqurashi, Thamer M. A.
Alghamdi, Badrah S.
Ashraf, Ghulam Md
Kazi, Mohsin
ADVANCEMENTS IN LIFE SCIENCES, 2024, 11 (01): : 136 - 143
[24] Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
Andersson, Malin E.
Sjolander, Annica
Andreasen, Niels
Minthon, Lennart
Hansson, Oskar
Bogdanovic, Nenad
Jern, Christina
Jood, Katarina
Wallin, Anders
Blennow, Kaj
Zetterberg, Henrik
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 20 (02) : 233 - 239
[25] WDR49-Positive Astrocytes Mark Severity of Neurodegeneration in Frontotemporal Lobar Degeneration and Alzheimer's Disease
Rajicic, Ana
Giannini, Lucia A. A.
Gerrits, Emma
van Buuren, Renee
Melhem, Shamiram
Slotman, Johan A.
Rozemuller, Annemieke J. M.
Eggen, Bart J. L.
van Swieten, John C.
Seelaar, Harro
GLIA, 2025, 73 (05) : 948 - 968
[26] Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith
Avila, Jesus
JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 : S265 - S270
[27] Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease
Xing, Feng
Meng, Tao
Therriault, Joseph
Luo, Jing
Zhang, Hua
JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2021, 20 (02) : 277 - 286
[28] GRK5 influences the phosphorylation of tau via GSK3 and contributes to Alzheimer's disease
Zhao, Jianghao
Li, Xiaohui
Chen, Xiongjin
Cai, Yujie
Wang, Yan
Sun, Wenjing
Mai, Hui
Yang, Jingqi
Fan, Weihao
Tang, Pei
Ou, Mingqian
Zhang, Yuan
Huang, Xuemei
Zhao, Bin
Cui, Lili
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10411 - 10420
[29] Experimental and theoretical studies on structural changes in the microtubule affinity-regulating kinase 4 (MARK4) protein induced by N-hetarenes: a new class of therapeutic candidates for Alzheimer's disease
Haque, Ashanul
Alenezi, Khalaf M.
Rasheed, Mohd. Saeed Maulana Abdul
Rahman, Md. Ataur
Anwar, Saleha
Ahamad, Shahzaib
Gupta, Dinesh
FRONTIERS IN MEDICINE, 2025, 12
[30] An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration
Walton, J. R.
JOURNAL OF INORGANIC BIOCHEMISTRY, 2007, 101 (09) : 1275 - 1284

← 1 2 3 4 5 →